Abnormal tumor necrosis factor receptor I cell surface expression and NF‐κB activation in tumor necrosis factor receptor–associated periodic syndrome

Abstract

High levels of TNFRI at the cell surface in patients with the C73R mutation hypersensitizes cells to stimulation by TNF, leading to increased NF-kappaB p65 subunit activation and an exaggerated proinflammatory response.